In Brief: McNeil Consumer Products
This article was originally published in The Tan Sheet
Executive Summary
McNeil Consumer Products: Firm supports three-year marketing exclusivity for SmithKline Beecham's recently approved Nicorette and Nicorette DS smoking cessation gum in comments filed with FDA on Feb. 9. The comments oppose a Nov. 2 citizen petition urging that Nicorette not be granted exclusivity, filed by McKenna & Cuneo on behalf of an unnamed client ("The Tan Sheet" Nov. 20, 1995, p. 2). McNeil says, "To deny exclusivity in such instances, and permit introduction of generic copies immediately upon approval of such OTC switch products, would have a chilling effect on innovation in the OTC industry and, thus, should not be permitted"...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning